BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Total Current Liabilities

Latest total current liabilities for LSBPW: $820M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$824.75M
2.81% YoYΔ $22.53M vs prior year quarter

Peer average

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Total Current Liabilities History

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) vs. peers: Total Current Liabilities Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) FAQ

As of the most recent data (March 2025), LSBPW shows a total current liabilities of $820M. That compares with $800M in the prior-year period — up 2.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSBPW's total current liabilities is now $820M (was $800M) — a 2.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

Tracking LSBPW's total current liabilities over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $820M That compares with $800M in the prior-year period — up 2.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $820M) with ownership activity and broader fundamentals.